Grant · EU
ScreenIn3D: A novel therapeutic antibody to improve cancer treatment through the elimination of senescent cells
Awarded a £102k Eu grant for "A novel therapeutic antibody to improve cancer treatment through the elimination of senescent cells".
- Company
- ScreenIn3D
- Funder
- EU
- Amount
- £102k
- Programme
- EU-Funded
- Role
- Lead organisation
- Dated
- 1 Jun 2022
- Record
- UKRI Gateway to Research
ScreenIn3D's other grants
Scottish tech in one email,
every Monday.